SCHEMBL14428006

SCHEMBL14428006

CCN(CC)CCOCCN1c2ccccc2C(C)(C)C12C=Nc1c(ccc3ccccc13)O2

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.61
KDM4E B2RXH2 8/20 0.61
THRB P10828 6/20 0.61
SMN1; SMN2 Q16637 5/20 0.61
ALOX12 P18054 2/20 0.61
L3MBTL1 Q9Y468 2/20 0.61
PKM P14618 2/20 0.61
LMNA P02545 5/20 0.51
ALDH1A1 P00352 4/20 0.51
GAA P10253 4/20 0.51
TDP1 Q9NUW8 4/20 0.51
HPGD P15428 3/20 0.51
HTT P42858 3/20 0.51
RECQL P46063 3/20 0.51
POLB P06746 1/20 0.51
MAPK1 P28482 1/20 0.51
CYP3A4 P08684 3/20 0.40
NPSR1 Q6W5P4 3/20 0.40
CYP2C19 P33261 2/20 0.40
CYP2C9 P11712 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14427987 0.91 MAPT (0.68) MAPTKDM4ETHRBSMN1; SMN2ALOX12
SCHEMBL14440509 0.90 MAPT (0.67) MAPTKDM4ETHRBSMN1; SMN2ALOX12
SCHEMBL14439755 0.90 MAPT (0.58) MAPTKDM4ETHRBSMN1; SMN2ALOX12
SCHEMBL13619795 0.89 MAPT (0.66) MAPTKDM4ETHRBSMN1; SMN2ALOX12
SCHEMBL14077749 0.89 MAPT (0.68) MAPTKDM4ETHRBSMN1; SMN2ALOX12
SCHEMBL13619825 0.89 MAPT (0.56) MAPTKDM4ETHRBSMN1; SMN2ALOX12
SCHEMBL14428005 0.88 KDM4E (0.48) MAPTKDM4ETHRBSMN1; SMN2ALOX12
SCHEMBL14428011 0.85 MAPT (0.42) MAPTKDM4ETHRBSMN1; SMN2ALOX12
SCHEMBL14428008 0.85 MAPT (0.42) MAPTKDM4ETHRBSMN1; SMN2ALOX12
SCHEMBL14427988 0.85 MAPT (0.67) MAPTKDM4ETHRBSMN1; SMN2ALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070195309-A1 PHOTOCHROMIC PROBES WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2007-08-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070195309-A1 PHOTOCHROMIC PROBES ORAI1, TRPC1, STIM1 MAPT 1551/4885KDM4E 2669/4885THRB 4313/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.